Bio-Techne Corp
NASDAQ:TECH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bio-Techne Corp
NASDAQ:TECH
|
US |
|
IGM Financial Inc
TSX:IGM
|
CA |
|
O
|
Olympia Financial Group Inc
TSX:OLY
|
CA |
|
P
|
Phoenix Group Holdings PLC
F:1BF
|
UK |
Wall Street
Price Targets
TECH Price Targets Summary
Bio-Techne Corp
According to Wall Street analysts, the average 1-year price target for
TECH
is 76.73 USD
with a low forecast of 65.65 USD and a high forecast of 84 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TECH's stock price target?
Price Target
76.73
USD
According to Wall Street analysts, the average 1-year price target for
TECH
is 76.73 USD
with a low forecast of 65.65 USD and a high forecast of 84 USD.
What is Bio-Techne Corp's Revenue forecast?
Projected CAGR
6%
For the last 13 years the
compound annual growth rate for
Bio-Techne Corp's revenue is
11%.
The projected
CAGR
for the next 3 years is
6%.
What is Bio-Techne Corp's Operating Income forecast?
Projected CAGR
24%
For the last 13 years the
compound annual growth rate for
Bio-Techne Corp's operating income is
3%.
The projected
CAGR
for the next 3 years is
24%.
What is Bio-Techne Corp's Net Income forecast?
Projected CAGR
76%
For the last 13 years the
compound annual growth rate for
Bio-Techne Corp's net income is
-3%.
The projected
CAGR
for the next 3 years is
76%.
